logo
Sign in

PCRX Stock Price, Chart, Stats & News

Pacira BioSciences, Inc.
Save
893.30M
Market cap
174.69x
Current P/E
7.61x
Forward P/E

PCRX chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
77.41%
Operating margin
2.76%
Pretax margin
2.32%
Net margin
0.97%
Effective tax rate
58.31%
ROA
0.56%
ROE
0.95%
D/E
0.66x
Interest coverage ratio
1.19x

PCRX valuation

P/E
174.69x
P/S
1.36x
P/B
1.40x
P/CF
6.40x
P/FCF
7.20x
P/OCF
6.40x
PEG
-2.05x
EV multiple
5.65x

About

Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves.

Similar securities

Based on sector and market capitalization

Report issue